Title: Towards An Ethics of the Human Genome Project
1Towards An Ethics of the Human Genome Project
- Pattle P.Pun,
- Department of Biology,
- Wheaton College,
- Wheaton, IL 60187
- USA
2(No Transcript)
3What does the draft human genome sequence tell
us?
By the Numbers The human genome contains 3164.7
million chemical nucleotide bases (A, C, T, and
G). The average gene consists of 3000 bases,
but sizes vary greatly, with the largest known
human gene being dystrophin at 2.4 million
bases. Â The total number of genes is estimated
at 30,000 to 35,000 much lower than previous
estimates of 80,000 to 140,000 that had been
based on extrapolations from gene-rich areas as
opposed to a composite of gene-rich and gene-poor
areas. Â Almost all (99.9) nucleotide bases are
exactly the same in all people. Â The functions
are unknown for over 50 of discovered genes.
Human Genome Program, U.S. Department of Energy,
Genomics and Its Impact on Medicine and Society
A 2001 Primer, 2001
4What does the draft human genome sequence tell us?
How It's Arranged The human genome's gene-dense
"urban centers" are predominantly composed of the
DNA building blocks G and C. Â In contrast, the
gene-poor "deserts" are rich in the DNA building
blocks A and T. GC- and AT-rich regions usually
can be seen through a microscope as light and
dark bands on chromosomes. Â Genes appear to be
concentrated in random areas along the genome,
with vast expanses of noncoding DNA between. Â
Stretches of up to 30,000 C and G bases repeating
over and over often occur adjacent to gene-rich
areas, forming a barrier between the genes and
the "junk DNA." These CpG islands are believed to
help regulate gene activity. Â Chromosome 1 has
the most genes (2968), and the Y chromosome has
the fewest (231).
Human Genome Program, U.S. Department of Energy,
Genomics and Its Impact on Medicine and Society
A 2001 Primer, 2001
5What does the draft human genome sequence tell
us?
The Wheat from the Chaff Less than 2 of the
genome codes for proteins. Â Repeated sequences
that do not code for proteins ("junk DNA") make
up at least 50 of the human genome. Â
Repetitive sequences are thought to have no
direct functions, but they shed light on
chromosome structure and dynamics. Over time,
these repeats reshape the genome by rearranging
it, creating entirely new genes, and modifying
and reshuffling existing genes. Â
Human Genome Program, U.S. Department of Energy,
Genomics and Its Impact on Medicine and Society
A 2001 Primer, 2001
6What does the draft human genome sequence tell
us?
Variations and Mutations Scientists have
identified about 1.4 million locations where
single-base DNA differences (SNPs) occur in
humans. This information promises to
revolutionize the processes of finding
chromosomal locations for disease-associated
sequences and tracing human history. Â The
ratio of germline (sperm or egg cell) mutations
is 21 in males vs females. Researchers point to
several reasons for the higher mutation rate in
the male germline, including the greater number
of cell divisions required for sperm formation
than for eggs.
Human Genome Program, U.S. Department of Energy,
Genomics and Its Impact on Medicine and Society
A 2001 Primer, 2001
7Medicine and the New Genomics
- Gene Testing
- Gene Therapy
- Pharmacogenomics
Anticipated Benefits
- improved diagnosis of disease
- earlier detection of genetic predispositions to
disease - rational drug design
- gene therapy and control systems for drugs
- personalized, custom drugs
Human Genome Program, U.S. Department of Energy,
Genomics and Its Impact on Medicine and Society
A 2001 Primer, 2001
8Huntington Disease (HD)and Cystic Fibrosis (CF)
- How are HD and CF inherited? What are the
patterns of inheritance? - What is the cause of HD? Of CF? Whats wrong with
the HD or CF genes? - What is the predictive reliability of the genetic
test that determines whether an individual
carries a gene for HD? For CF?
9What is the clinical course of HD?
- HD is typically a late manifesting autosomal
dominant neurodegenerative disorder. It is
characterized by motor disturbances, loss of
cognitive functions, and psychiatric
manifestations. HD patients present with loss of
coordination, worsening gait, constant
uncontrolled movements (chorea) and personality
changes.
10- After diagnosis, HD patients require medical
intervention and as the disease worsens patients
invariably require specialized care in long-term
nursing facilities. Death comes within 15 years
after the initial clinical diagnosis of HD.
11What is the HD gene?
- The HD gene is represented by a segment of DNA
(approximately 300,000 letters) found on human
chromosome 4. - Approximately 3 of the letters of the HD gene
are expressed as the HD protein, which has been
named huntingtin. - Although HD is relatively rare (both inherited
and de novo case), every human possesses two
alleles of the HD gene.
12Whats wrong with the HD gene?
- The variant HD alleles which cause HD have a
molecular abnormality consisting of an expanding
triplet repeat (CAG). - The expanding triplet repeat causes extra
glutamine amino acids to be placed within the
front end of the huntingtin protein, making
huntington bigger.
13The genetic test that measures the presence of
the HD disease alleles.
- The original HD test was based on genetic markers
that were close to the HD gene. These tests were
about 95 reliable (sometimes crossing over would
break the linkage). - The current test is based on the direct
assessment of the exact size of the expanding
triplet repeat region of the HD gene. This is a
much more reliable test, more than 99.5
accurate.
14The genetic test that measures the presence of
the HD disease alleles.
- Alleles of HD which have between 10 and 35 (CAG)
repeats never cause HD. - Alleles of HD which have more than 40 (CAG)
repeats always cause HD. - Alleles of HD which have between 36 and 39 (CAG)
repeats almost always causes HD.
15Clinical Diagnosis of CF
- Typical pulmonary manifestations.
- Typical gastrointestinal manifestations.
- A history of cystic fibrosis in the immediate
family. - Sweat chloride concentrations greater than a
baseline value. - Identification of pathological CFTR mutations on
both CFTR alleles. - Occasionally, CF is uncovered by a discovery of
male infertility.
16Consequence of CF
- CF patients have greatly shortened life
expectancy. The mean age of death now is around
30. - There is no cure for cystic fibrosis.
- Cystic fibrosis is a fatal disease.
17Inheritance of CF
- Cystic Fibrosis is a autosomal recessive disease.
It is caused by a single gene defect which is
inherited in a autosomal recessive mendelian
fashion. Both alleles of the CF gene must be
affected to be at risk of CF. Having a single
allele of the CF gene makes the individual a
carrier, but does not produce CF.
18Identification of the CF gene
- The CF gene, now called CFTR, was identified in
1989 by several groups, including Francis
Collins, the current director of the NIH Human
Genome Institute.
19Genotype and Phenotype correlation in CF
- Many symptoms are common to all CF patients, such
as salty sweat. - There is a reasonably good correlation of
genotype (particular CF alleles) and pancreatic
function. - There is little or no correlation of genotype and
severity of lung disease or other clinical
symptoms. Lack of concordance in twin studies.
20Gene therapy for cystic fibrosis
- Gene therapy for cystic fibrosis has been
evaluated in several human clinical trials.
21Behavior is Multifactorial
Sin?
Environment
Genes
Development
Behavior
22Classical Methods for Studying the Relationship
between Genes and Behavior
- Twins
- Same genes different environments
- Adoptees
- Different genes same environment
23Heritability of Various Psychiatric Diseases,
Personality Traits And Behaviors
- Phenotype Heritability
- Schizophrenia .60
- Bipolar disorder .62
- Major depression .40
- Social phobia .52
- Panic disorder .42
- Generalized anxiety disorder .35
- Neuroticism .52
- Extraversion .38
- Novelty Seeking .45
- Cigarette smoking .60
- Divorce .52
- Religious affiliation .00
Heritability is the fraction of total
variability due to genetic differences. It is
determined by studying twins and adoptees.
24Although many behaviors are partially heritable,
most of the genes are unknown
- For example
- Schizophrenia and Bipolar DisorderDozens of
loci have been identified by linkage mapping, but
only a few have been replicated in at least one
study and none in every study. No specific genes
have been found. - Personality traits such as Neuroticism and
Novelty SeekingSpecific genes have been found,
but they account for only a few percent of total
variance.
25Behavior Gene Discovery
- Complications
- Multiple genes
- Environment is important
- Pleiotropy
- Measurement
Mapping Genes To Traits
Mapping Traits To Genes
Trait 1 Gene Trait 2
Trait 3
Gene 1 Trait Gene 2 Gene 3
26The Number of Genes Involved in Particular
Behaviors is Unknown
gene 1
environment
gene 6
or
?
gene1
environment
gene 100
27The Advent of Genomic Medicine
- The science of genomics rests on direct
experimental access to the entire human genome
and applies to common conditions, such as breast
cancer and colorectal cancer, human
immunodeficiency virus (HIV) infection,
tuberculosis, Parkinson's disease, and
Alzheimer's disease. These common disorders are
also all due to the interactions of multiple
genes and environmental factors. They are thus
known as multifactorial disorders. Genetic
variations in these disorders may have a
protective or a pathologic role in the expression
of diseases
28Two case vignettes (I)
- Thirty-four-year-old Kathleen becomes pregnant
and sees a new physician for her first prenatal
visit. - Her medical history is remarkable for an episode
of deep venous thrombosis five years earlier
while she was taking oral contraceptives - her mother had had deep venous thrombosis when
pregnant with Kathleen. - Her physician suspects that Kathleen has a
hereditary thrombophilia and obtains blood tests
to screen for a genetic predisposition to
thrombosis. - Kathleen proves to be among the approximately 4
percent of Americans who are heterozygous for a
mutation in factor V known as factor V Leiden
that increases the risk of thrombotic events. - On the basis of this knowledge and her history of
possibly estrogen-related thromboembolism, she is
treated with prophylactic subcutaneous heparin
for the balance of her pregnancy. She remains
asymptomatic and delivers a healthy, term infant.
29Two case vignettes (II)
- Four-year-old John has acute lymphoblastic
leukemia and tolerates induction and
consolidation chemotherapy well, with minimal
side effects. - As a key part of his maintenance-treatment
protocol, he begins to receive oral
mercaptopurine daily, but because a genetic test
shows that John is homozygous for a mutation in
the gene that encodes thiopurine
S-methyltransferase, an enzyme that inactivates
mercaptopurine, he receives a greatly reduced
dose. - Only a few years ago, about 1 in 300 patients had
serious, sometimes lethal, hematopoietic adverse
effects during mercaptopurine therapy. Although
John is in this at-risk minority, a simple
genetic test, which is now routine for patients
beginning mercaptopurine therapy, alerts his
physicians to this genetic predisposition. - They reduce his dose of mercaptopurine and
carefully monitor his blood levels, ensuring that
the drug levels remain therapeutic, rather than
toxic. - John subsequently has an uneventful several-year
maintenance period and achieves complete
remission.
30The Cypriot ParadigmThe Journal of Medicine and
Philosophy   Volume 23, Number 3 / July 1998 Â
Pages 274 - 287 Geneticization The Cyprus
Paradigm
- Genetic Testing for Thalassemia for Greek
Cypriots - Government and church cooperate in public
education, counseling and clinical service. - Small, homogeneous population
- Fairly high living standard
- High literacy rate.
- Within One Generation, disease rate fell from
1/1000 births to 0 in 1986. - No more reported case as of 1992.
31Sustained Correction of X-Linked Severe Combined
Immunodeficiency by ex Vivo Gene Therapy, NEJM
3461185-1193 April 18, 2002
- Methods
- CD34 bone marrow cells from five boys with
X-linked severe combined immunodeficiency were
transduced ex vivo with the use of a defective
retroviral vector. Integration and expression of
the c transgene and development of lymphocyte
subgroups and their functions were sequentially
analyzed over a period of up to 2.5 years after
gene transfer.
32Sustained Correction of X-Linked Severe Combined
Immunodeficiency by ex Vivo Gene Therapy
- Results
- No adverse effects resulted from the procedure.
Transduced T cells and natural killer cells
appeared in the blood of four of the five
patients within four months. The numbers and
phenotypes of T cells, the repertoire of T-cell
receptors, and the in vitro proliferative
responses of T cells to several antigens after
immunization were nearly normal up to two years
after treatment. Thymopoiesis was documented by
the presence of naive T cells and T-cell
antigen-receptor episomes and the development of
a normal-sized thymus gland. The frequency of
transduced B cells was low, but serum
immunoglobulin levels and antibody production
after immunization were sufficient to avoid the
need for intravenous immunoglobulin. Correction
of the immunodeficiency eradicated established
infections and allowed patients to have a normal
life.
33The case of Jesse Gelsinger
34 The Case (1)Jesse Gelsinger was born
with an X-linked recessive error of metabolism,
ornithine transcarbamylase deficiency (OTC).
This disease causes a life threatening buildup
of ammonia. Half of the youngsters born with the
disease die within hours of birth. Jesses case
was relatively mild and was controlled with
drugs. Even so, he had experienced one serious
episode of coma.
35 Gelsinger (2)When Jesse turned 18, he
volunteered for a gene transfer trial at the
University of Pennsylvania. The bioethics
committee supervising the trial would not accept
affected newborns on the grounds that the parents
would be too distraught to provide informed
consent. Jesse was jubilant on being accepted.
Whats the worst that can happen to me, he
said. I die and its for the babies.
36 Gelsinger (3)After two lower dosage
trials on other volunteers, Jesse was
administered the highest dosage level of an
adenovirus vector, with the functional OTC gene
stitched into it. This vector had already been
safely used in over 80 gene therapy trials
involving approximately 1,000 patients.
37 Gelsinger (4)Jesse entered the
hospital on September 13, 1999. Seventeen others
in the trial had already been treated and
suffered only minor aches and pains. However,
Jesse soon suffered a high fever. His ammonia
levels skyrocketed and eventually he suffered
lung failure and brain death.
38 Gelsinger (5)Doctors later explained
that, because of a previous infection, Jesse had
had an acute immune reaction to the adenovirus.
In the months following his death, FDA and NIH
officials identified a host of procedural
irregularities and problems that contributed to
Jesses death.
39Safety and Consent in GT Research Several
lessons of the Jesse Gelsinger Case
- The risks of this research
- The need for better adverse event reporting and
fully informed consent
40Therapy
Enhancement
Somatic
Germ Line
41Sources of Concern
- Insertional mutagenesis and the iatrogenic
creation of genetic disorders - The enduring nature and proliferating potential
of such mishaps - The low level of need prenatal and
preimplantation selection and egg or sperm
donation obviate most Germ Line GeneTherapy
42- Can genetic testing be a tool for discrimination
by social institutions such as the insurance
industry? - What is the limitation of genetic technologies?
- By what criteria can we evaluate the use or
misuse of human genetic information?
43- How far should one pursue to improve the human
conditions by genetic manipulation? - How can we prevent the abuse of human genetic
information? - Does the presence of the genetic defect doom the
future of a child's life? - Do parents have a right not to be subject to
genetic testing to alleviate anxiety?
44- Are medical professionals obligated to counsel
patients in making these decisions? - Should employers or insurance companies be given
free access to the genetic information of
potential employees or clients to determine their
employability or set the insurance rates?
45- What professional standards should be set for a
physician in regards to the amounts and varieties
of genetic testing required for his patients by
which malpractice litigation can be measured? - Does a person have a right not to know about his
genetic makeup? - Will genetics become a weapon for social
discrimination?
46Purdy
- It can sometimes be immoral to have children when
we know (or should know) that our offspring may
have a genetic disease.
47JC Peterson
- Improvement of our genetic heritage is a
reflection of Gods gracious redemption if done
properly.
48A. Various Ethical Principles informed by the
Christian Worldview
491. Divine Law of Aquinas and Augustine
- The Creator has designed purposes and directions
for His creation. This Divine Law can be
discovered in Nature. Despite man's sinful
nature, God still reveals this Law to man through
the Scripture and the Church. The Divine Law is
consonant with human nature and can be
universally applied.
502. God's Steward in His Creation
- Human's participation in creation as a
significant part of man's stewardship of God's
creation demands his respect for nature, not his
exploitation. Man has to maintain two attitudes
in exercising his stewardship of nature to be
grateful towards his Creator, and to be prudent
towards managing the creation.
513. The Ethics of Virtue
- A virtuous person is driven to do good deeds not
by the mores of his institutions, but by his own
virtuous disposition. The Scriptures define
virtuous disposition as the internal desire to be
good and to do good, not only based on ones'
education and upbringing, but on the freedom from
the bondage of sin and the fruits of the Holy
Spirit in a repentant sinner.
52B. Towards a Christian Model of Ethics What
Constitute a Perfect Human Being?
- Therefore you are perfect, as your heavenly
Father is perfect Mt. 548
53The concept of a Perfect Human Being as defined
by scriptural perspectives should help in the
discussion of the ethics of HGP since it defines
the essence of what is being human as well as the
criteria by which genetic technologies should be
applied particularly in relation to man himself.
54 A Perfect Human Being
551. Creature of God Confined by Finitude
- There is a limit within which human intervention
to save life can operate since man is doomed to
die because of our sin. However, advancement in
medical and genetic technologies can ultimately
be the instruments that God uses to manifest His
work in ameliorating the effects of sin and decay
562. Created to Enjoy and Glorify God
- Health can be defined more holistically as "the
strength to be human, not to pursue total
fulfillment. The paradox of the evils in the
world under the benevolence of the Creator can
only be solved in the death and resurrection of
Jesus Christ. While eliminating human suffering
is a noble cause, there may be a higher purpose
for some incurable diseases after all human
efforts are exhausted.
573. Made Alive by the Direct Involvement of God
- God's direct involvement in human life is evident
in the act of breathing into the nostrils of man
in creation. Genetic engineering of germ cells or
the cloning of adult human beings cross the
border line of depriving the offspring yet to be
born of the freedom to choose the direction of
his/her life, a gift uniquely given only by the
Creator Himself.
584. Created to be God's Steward
- As stewards of God's creation, Christians should
be the salt and light of the world and actively
provide leadership in establishing ethical
principles for the HGP, instead of being the
obscurantists who oppose technological advance
for the sake of tradition.
595. Created in His Image Divine Moral Law
- All human beings are created in the Image of God.
Although the Fall depraved man's divine
conscience, the church and the social
institutions have the obligations to uphold God's
Divine Moral Laws which are meant to bring
welfare to individuals and to societies. The
Golden Rule was meant for the survival and
stability of human society. The genetic
information of individuals should be guarded as
one's private property and is to be protected
against unjustified intrusion.
606. Creature Representing Creation to God
- The Fall brought about the three fold alienation
of man (1) with the Creator, (2) with fellow
creatures, (3) with the creation, resulting in
the loss of spiritual, social and physical
health respectively. Man representing the
creation in reconciliation in each of these 3
levels through Jesus Christ brings man into
harmony with God and the creation in the healing
process. Without the covenantal relationship of
reconciliation in each of these 3 levels,
holistic health cannot be achieved
617. Conformed to the Image of the Incarnate Word.
- Based on the historical fact of Christ's
resurrection, the redemption of our bodies at
Christ's second coming is the consummation of all
creation, which eagerly awaits its liberation
from its bondage to decay and deliverance into
the glorious freedom of the children of God. By
conforming to the image of Christ, man is
justified and will be glorified when his lowly
body is transformed to be like His glorious body.
It is therefore wrong to look for the domination
of creation including the elimination of human
suffering outside the lordship of Christ in other
earthly powers such as those of the state and
science and technology
62- A Perfect Human Being
- 1. Creature of God Confined by Finitude
- 2. Created to Enjoy and Glorify God
- 3. Made Alive by the Direct Involvement of God
- 4. Created to be God's Steward
- 5. Created in His Image Divine Moral Law
- 6. Creature Representing Creation to God
- 7. Conformed to the Image of the Incarnate Word.
63An Attempt to Solve a Dilemma Genetic
Information Nondiscrimination Act of 2003
(revised 2005)
- http//thomas.loc.gov/cgi-bin/bdquery/z?d108SN010
53_at__at__at_Lsumm2msummary - http//www.govtrack.us/congress/bill.xpd?tabsumma
rybills109-306
641. Prohibition on Genetic Discrimination in
Employment and Insurance.
652. Establishing Uniform Rule to Protect Genetic
Privacy (i.e. HIPAA)
66HIPAA Health Insurance Portability and
Accountability Act of 1996
- PROTECTING THE PRIVACY OF PATIENTS' HEALTH
INFORMATION - The rule does not restrict the ability of
doctors, nurses and other providers to share
information needed to treat their patients. In
other situations, though, personal health
information generally may not be used for
purposes not related to health care, and covered
entities may use or share only the minimum amount
of protected information needed for a particular
purpose. In addition, patients would have to sign
a specific authorization before a covered entity
could release their medical information to a life
insurer, a bank, a marketing firm or another
outside business for purposes not related to
their health care. - http//www.hhs.gov/news/facts/privacy.html